Ali Younas Khan
Overview
Explore the profile of Ali Younas Khan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ehsan H, Wahab A, Shafqat M, Sana M, Khalid F, Abdullah S, et al.
J Blood Med
. 2020 Nov;
11:405-420.
PMID: 33173367
The blood transfusion (BT) system in Pakistan is fragmented, demand-driven and depends on weakly regulated transfusion practices. There is a considerable possibility that transfusion-transmissible infections (TTIs) are contributing to the...
2.
Jilani M, Iqbal H, Huda S, Khan A, Charlamb L
Cureus
. 2020 Jul;
12(7):e9202.
PMID: 32685329
Neurological complications after cardiac catheterization are rare. We report an unusual case of isolated third cranial nerve palsy in a 72-year-old male patient whose past medical history was significant for...
3.
Jilani M, Simon-Friedt B, Yahya T, Khan A, Hassan S, Kash B, et al.
Atherosclerosis
. 2020 Jul;
306:22-32.
PMID: 32682146
Background And Aims: Long-term exposure to particulate matter (PM) air pollution has been linked with increased cardiovascular events and mortality, however, studies had shown inconsistent associations between PM exposure and...
4.
Fraz M, Warraich F, Warraich S, Tariq M, Warraich Z, Khan A, et al.
Crit Rev Oncol Hematol
. 2019 Apr;
137:18-26.
PMID: 31014512
Multiple Myeloma (MM) is primarily a disease of old age with a median age of sixty-nine years at diagnosis. The development of novel therapies for induction and use of autologous...
5.
Extrapyramidal Symptoms with Administration of Lenalidomide Maintenance Therapy for Multiple Myeloma
Sagar F, Malik S, Soontornprueksa S, Ijaz A, Usman M, Khan A, et al.
Cureus
. 2018 Nov;
10(9):e3349.
PMID: 30483455
Lenalidomide is commonly used as induction or maintenance therapy in multiple myeloma. We report a case of 71-year-old female presenting with tardive dyskinesia-like symptoms one month after starting her lenalidomide...
6.
Jamil F, Khan H, Khan A, Anwer F
BMJ Case Rep
. 2018 Oct;
2018.
PMID: 30279261
No abstract available.
7.
Ijaz A, Khan A, Malik S, Faridi W, Fraz M, Usman M, et al.
Biol Blood Marrow Transplant
. 2018 Sep;
25(1):94-99.
PMID: 30195074
Investigators are using checkpoint inhibitors (CPIs) to treat aggressive hematologic malignancies in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) and in some patients with relapsed disease after allo-HSCT. CTLA-4...
8.
Kumar A, Fraz M, Usman M, Malik S, Ijaz A, Durer C, et al.
Curr Treat Options Oncol
. 2018 Sep;
19(10):50.
PMID: 30173370
R-CHOP has been the standard of care for diffuse large B cell lymphoma (DLBCL), curing approximately 60% of patients for more than 2 decades. However, the optimal treatment of patients...